Long Term Results of Single-Fraction Carbon-Ion Radiotherapy for Non-small Cell Lung Cancer.

Takashi OnoNaoyoshi YamamotoAkihiro NomotoMio NakajimaYuka IsozakiGoro KasuyaHitoshi IshikawaKenji NemotoHiroshi Tsuji

Published in: Cancers (2020)

This study suggests that single-fraction CIRT for T1-2N0M0 non-small cell lung cancer patients is feasible and can be considered as one of the treatment choices, especially in medically inoperable patients.

Keyphrases

end stage renal disease
chronic kidney disease
newly diagnosed
locally advanced
early stage
single cell
radiation therapy
prognostic factors
stem cells
radiation induced
bone marrow
patient reported outcomes